Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7633874rdf:typepubmed:Citationlld:pubmed
pubmed-article:7633874lifeskim:mentionsumls-concept:C0599755lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C0026565lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C1442488lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C0020029lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C1516879lld:lifeskim
pubmed-article:7633874lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:7633874pubmed:issue7lld:pubmed
pubmed-article:7633874pubmed:dateCreated1995-9-14lld:pubmed
pubmed-article:7633874pubmed:abstractTextWe describe baseline characteristics, enrollment, progression and mortality of the Edinburgh City Hospital HIV cohort. There were 431 men and 191 (31%) women; 439 (71%) infected via injection drug use (IDU); 92 (15%) via homosexual intercourse; 84 (13%) via heterosexual intercourse and 7 from blood products. Median annual rate of CD4 cell loss was 49 (90% range: 15-146); Both homosexual men and patients aged > 40 years at enrollment lost CD4 cells significantly more quickly. In multifactorial analysis controlled for baseline CD4 count and IgA, there was no gender effect, but young patients (< 25 years) progressed significantly more slowly to AIDS (RR 0.4, p = 0.00). Homosexual men progressed significantly more quickly than IDUs, with adjusted relative risks (RR) of 2.9 (p = 0.00), 2.5 (p = 0.01) and 1.5 (p = 0.1) for progression to CDC stage IV, AIDS and death, respectively. The three-year survival rate post-AIDS was 25% (SE 4.3) and there was no gender effect on survival. There was, however, an age effect whereby individuals diagnosed with AIDS in their 40s or later showed poorer survival (RR 1.9, p = 0.04). Zidovudine treatment after an AIDS diagnosis significantly lengthened post-AIDS survival (RR 0.5, p = 0.08).lld:pubmed
pubmed-article:7633874pubmed:languageenglld:pubmed
pubmed-article:7633874pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7633874pubmed:citationSubsetIMlld:pubmed
pubmed-article:7633874pubmed:statusMEDLINElld:pubmed
pubmed-article:7633874pubmed:monthJullld:pubmed
pubmed-article:7633874pubmed:issn1460-2725lld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:RichardsonAAlld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:GrayP HPHlld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:BrettleR PRPlld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:BirdA GAGlld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:McNeilA JAJlld:pubmed
pubmed-article:7633874pubmed:authorpubmed-author:LeenC SCSlld:pubmed
pubmed-article:7633874pubmed:issnTypePrintlld:pubmed
pubmed-article:7633874pubmed:volume88lld:pubmed
pubmed-article:7633874pubmed:ownerNLMlld:pubmed
pubmed-article:7633874pubmed:authorsCompleteYlld:pubmed
pubmed-article:7633874pubmed:pagination479-91lld:pubmed
pubmed-article:7633874pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:meshHeadingpubmed-meshheading:7633874-...lld:pubmed
pubmed-article:7633874pubmed:year1995lld:pubmed
pubmed-article:7633874pubmed:articleTitleThe Edinburgh City Hospital cohort: analysis of enrollment, progression and mortality by baseline covariates.lld:pubmed
pubmed-article:7633874pubmed:affiliationRegional Infectious Disease Unit, City Hospital, Edinburgh.lld:pubmed
pubmed-article:7633874pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7633874pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7633874lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7633874lld:pubmed